PenderFund Capital Management Ltd.
VANCOUVER, A1 · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$1.09B2026 Q3
Positions243
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.44.9%
What Changed This Quarter?
59 new stocks bought: EEFT 0.625 10-01-30 (6.7%), GFUZ (4.1%), ZS 0 07-15-28 (4.0%) +5647 positions fully exited: Evolent Health, ESPREUR, Teucrium Commodity Tr +44 Biggest add: OMCL 1 12-01-29 +984.2% in shares Biggest trim: Teucrium Commodity Tr -99.5% in shares
Top Holdings
NOG 3.625 04-15-29
Northern Oil &
7.1%
EEFT 0.625 10-01-30
Euronet Worldwide
6.7%
AGCN 0.375 01-15-27
First Majestic Silver
4.5%
VERX 0.75 05-01-29
Vertex
4.1%
GFUZ
General Fusion
4.1%
ZS 0 07-15-28
Zscaler
4.0%
WOLF 2.5 06-15-31
Wolfspeed
3.9%
FLNC 2.25 06-15-30
Fluence Energy
3.8%
New / Increased
59 new · 54 increased
EEFT 0.625 10-01-30NEW
Euronet Worldwide
6.7%
GFUZNEW
General Fusion
4.1%
ZS 0 07-15-28NEW
Zscaler
4.0%
FinvolutionNEW
Finvolution
3.0%
NTNX 0.5 12-15-29NEW
Nutanix
2.1%
OMCL 1 12-01-29
Omnicell
3.3%
+984.2%
WOLF 2.5 06-15-31
Wolfspeed
3.9%
+72.9%
IRTC 1.5 09-01-29
Irhythm
2.0%
+116.0%
Reduced / Exited
82 reduced · 47 sold out
Teucrium Comm…
Teucrium Commodity Tr
0.0%
-99.5%
Teucrium Comm…
Teucrium Commodity Tr
0.8%
-49.7%
Par Technology
Par Technology
0.9%
-33.3%
Opko Health
Opko Health
0.9%
-23.6%
PAR
Par Technology
0.9%
-10.4%
Evolent HealthEXIT
Evolent Health
2.4%
ESPREUREXIT
Esperion Therapeutics Inc
1.6%
Teucrium Comm…EXIT
Teucrium Commodity Tr
0.3%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.